Nav: Home

A hidden route for fatty acids can make cancers resistant to therapy

February 06, 2019

Fatty acid metabolism is an essential process in tumor growth and proliferation. Despite different attempts to block fatty acid metabolism as a therapeutic strategy to reduce tumor size and growth, the outcome was not always positive. Researchers from the lab of Prof. Sarah-Maria Fendt at the VIB-KU Leuven Center for Cancer Biology now demonstrate that certain tumor cells use an alternative - previously unexplored - pathway to produce fatty acids. This finding can explain the resistance of particular cancer types to fatty acid metabolism inhibition. It is essential to gain more insights in this process to develop novel therapeutic strategies. The results are published in the renowned journal Nature.

Tumors grow and proliferate, and to do so cancer cells require the duplication of building block molecules. This includes nucleotides to make DNA, but also fatty acids to make the cell boundaries i.e. the cell membrane. Not surprisingly, many cancer cells have upregulated metabolic reactions that lead to increased nucleotide and fatty acid production. Current developed therapies focus on the inhibition of nucleotide and fatty acid generation to block tumor growth. This strategy has proven to be successful in the case of nucleotide metabolism: chemotherapeutic agents currently used in cancer treatment such as 5FU and methotrexate inhibit tumor growth by targeting nucleotide generation. Surprisingly however, this effort had limited success for fatty acid metabolism inhibition.

Kim Vriens, Stefan Christen and colleagues in the lab of Sarah-Maria Fendt (VIB-KU Leuven) addressed the question why many cancer cells are resistant to the inhibition of fatty acid metabolism, and particular to the inhibition of the enzyme stearoyl-CoA desaturase (SCD). This enzyme has always been considered to be the only source of newly produced mono-unsaturated fatty acids, which are required for membrane generation. However, the researchers now found that some cancer cells exploit a unusual metabolic pathway to produce mono-unsaturated fatty acids. This pathway - novel in cancer cells - requires the enzyme fatty acid desaturase (FADS2) and results in the production of the unusual fatty acid sapienate. The presence of this novel and alternative metabolic pathway was identified in isolated cancer cells and in lung and liver tumors samples from mice and human patients.

Prof. Sarah-Maria Fendt (VIB-KU Leuven Center for Cancer Biology): "The newly discovered sapienate metabolism constitutes an alternative route for cancer cells to process the fatty acids required for membrane synthesis. These findings can explain the resistance of many cancer types to the inhibition of fatty acid desaturation. Since fatty acids are essential for tumor growth we expect that further dissection of the sapienate metabolism pathway will lead to a better understanding of how cancer cells grow and will thus open new avenues to better target this deadly disease. Moreover, this exciting discovery was supported by a fruitful collaboration between basic scientists and clinicians across three continents."
-end-
Publication

Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity, Vriens et al., Nature 2019

VIB (the Flanders Institute for Biotechnology)

Related Cancer Cells Articles:

Cancer cells send signals boosting survival and drug resistance in other cancer cells
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Single gene encourages growth of intestinal stem cells, supporting 'niche' cells -- and cancer
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Prostate cancer cells grow with malfunction of cholesterol control in cells
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Immune therapy scientists discover distinct cells that block cancer-fighting immune cells
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
New system developed that can switch on immune cells to attack cancer cells
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Sleep hormone helps breast cancer drug kill more cancer cells
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.

Related Cancer Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...